Category: Money tips Release Date: 2006-01-05
Source: Tiantong Securities Author: Zhang Rui
Strong broader market this week, finishing, contour shape of the structure of multi-gun attack that the market is a new high capacity still exists. Investors should closely monitor the hot spot changes in the bull market, once the mainstream hot switch was successful, then the market's hot bound has mainstream plate triggered by last week's market, non-ferrous metal fatigue has been vivid, while the aerospace defense of the strengths and needs of medical plates aggressive investors should pay close attention to next week, Thursday we have a low investment analysis military concept stock price Friday G Fushun Special Steel opened firmly sealed limit-board analysis of the reasons because of the existence of such varieties of its own two compensatory growth of kinetic energy, one is from the same industry with the concept of individual stocks short-term or larger, 2 to-year gains were of such shares arising from the dual delay retaliatory compensatory growth needs. As the plate in the aerospace defense industry stocks have accumulated a larger majority of the gains, so we tend to the overall aggressive with the medical board, in 2005 the plate had been the focus of attention of institutional .2006 years, medical section of the overall interaction stronger, its high operational efficiency to make money is with great shock to the markets, not to mention Tong Ren Tang, Man Niu Yunnanbaiyao this species, in the short term, it is astonishing scene is taking place: the Department of Pharmaceutical company closed four limit-, Jilin Pharmaceutical company closed three limit-Sinopharm science and technology, G Wikipedia Pharmaceutical, G Haiyao, G Jiang Chinese medicine, and so basically all pharmaceutical companies is that even the closed limit up, the overall pharmaceutical stocks recently a great boom to replace the non-ferrous metals market leader as hot, so there's a monopoly characteristics and are still looking for the bottom of the medicine with varieties will be next week, a key operation. G Hai-ching (600,267): is such a dual compensatory growth momentum stocks. Companies are involved in cardiovascular disease, diabetes and other diseases closely related to a new generation of research and development of drugs and their preparations. Recognized by the State Pharmaceutical Administration of antibiotics anticancer drugs for the country's production base, is the only designated participation "MDR-TB" Global cooperation project in China's pharmaceutical companies. Monopolistic advantages are obvious in the first quarter acquired QFII United States Shigekura more than 870 million shares, the company's future development patterns in combination with standard breakthroughs in medical stocks have a continuous limit-state of excitement, coupled with the bottom of the unit has been in a historic area, and the current round Quotes gains were seriously lagging behind compared to the same there is such a large The compensatory growth requirements, technical and our analysis of the Unit G-Fushun Special Steel to start when there is similar to the Miao, the recent stock showing a continuous moderate contribution, indicates that stock price will explode at any time. As the stock or backward, so the outbreak of the intensity of their presumably is staggering.
Organization grab chips medicine has become a fact! 2005 annual report, a number of leading pharmaceutical company's list of top ten shareholders of tradable shares in order to fund and pension fund on behalf of institutional investors accounted for almost all the seats, China Life also has implications for medicine showed a greater interest in shares. Basically, each fund companies have been carried out in the pharmaceutical industry, asset allocation, Castrol, sea Fortis and other large investment fund company. Among them, the Castrol Castrol's value-added services industries, Castrol growth and income jointly owned 595 million shares of Pien Tze Huang, Tasly 591 million shares, shares of Tong Ren Tang 1635; Castrol Castrol growth and income growth and holds a total of Tong Ren Tang 900 million shares. Sea Fortis Fortis's earnings growth in the sea, sea Fortis selection, sea Fortis shares of common shares held by G Huahai 1209; Hai Tong Ren Tang Fortis earnings growth to 604 million holdings; sea Fortis shares held Yunnanbaiyao 203 million; sea Fortis earnings growth to hold Hengrui Medicine 300 million shares. China Life Insurance Department of Pharmaceutical stocks were also popular for high-quality for me. China Life Insurance Company Limited to buy 416 million shares of Tong Ren Tang, holding Tasly 448 million, while China Life Insurance (Group) Company is also buying 261 million shares Tasly. In addition, the social security funds are also split up actions of the few blue chip stocks only pharmaceutical clean sweep. Social Security Fund portfolio holdings of Tong Ren Tang 106 to 551 million shares, and holds 495 million shares Yunnanbaiyao; the social security fund portfolio holds 602 202 shares Yunnanbaiyao; Social Security Fund to buy 104 new portfolio of 3.14 million Tasly shares, bought 324 million shares Huahai G; the social security fund portfolio holdings of 110 to 267 million Hengrui Medicine.
G Hai-ching (600,267): companies are involved in cardiovascular disease, diabetes and other diseases closely related to a new generation of research and development of drugs and their preparations. Recognized by the State Pharmaceutical Administration of antibiotics anticancer drugs for the country's production base, is the only designated participation "MDR-TB" Global cooperation project in China's pharmaceutical companies. Monopoly obvious advantages.
In recent years, tuberculosis a serious threat to human health caused widespread concern in the international community, the World Health Organization has been the focus of TB control infectious diseases. According to a recent WHO statistics show that approximately one third of people worldwide have been infected with TB; estimated global annual increase of Chao Guo 8000000-12000000 TB cases, with an average every second there is a contracted the disease; annual global deaths due to TB as high as 2000000-3000000 people. In fact, TB has become the number one killer among infectious diseases. China is the world's second largest high-TB countries, second only to India. More than one third of TB cases occurred in China. Chinese patients with the disease die every year as high as 13 million people. In China, 40% of TB patients have drug resistance, 10% of patients of multi-drug resistance. At the same time a long course of treatment for tuberculosis, complicated and costly. Improper or incomplete treatment can lead to widespread drug resistance mutations to treatment of tuberculosis diseases. This situation is causing great threat to public health.
TB cure is probably the most difficult case of MDR-TB. It is estimated that each one's life in patients with MDR-TB will infect more than 20 people. "Capreomycin is the main antibiotic treatment of tuberculosis. The world's drug treatment needs an annual volume of at least 120 million tons. Great demand corresponds to a serious shortage of production capacity." Faced with this grim situation, Eli Lilly and Company sponsored organized a "multi-resistant kinds of drug-TB "global cooperation project aimed at the joint parties to the global MDR-TB patients with high quality and affordable drugs, and find ways to prevent, treat and monitor disease, the best solution. To participate in this cooperation project members include WHO, International Council of Nurses (ICN), Harvard Medical School (Harvard Medical School), and Purdue University (Purdue University), and high incidence rates of the country's leading pharmaceutical companies and government stakeholders. March 24, 2006, the famous multi-national pharmaceutical company Eli Lilly and Company and domestic well-known pharmaceutical companies Hisun Pharmaceutical jointly announced by Eli Lilly and Company provided free of charge transfer of sea Pharmaceutical capreomycin production line is being verified by Eli Lilly and Company recognition, which marks the sea is medicine already has the same with the Eli Lilly drug capreomycin production of raw materials. Has been designated as the only participation "MDR-TB" Global cooperation project in China's pharmaceutical enterprises, and is the world's second Eli Lilly and Company to take advantage of patented technology to produce high-quality capreomycin company, also means that companies to enter the including WHO and other international cooperation in circle on the company's long-term development would constitute a far-reaching impact. Meanwhile, the sea is medicine also has been fatal to the global TB patients within the drug production conditions.
The secondary market, G sea positive (600,267) shares were hovering at the bottom of a long-term, in other pharmaceutical companies have a continuous daily limit under its own outbreak of accumulated had been very strong desire of the Japanese line of continuous contribution, triangle finishing The success of a breakthrough multi-week online gun attack on the standard form, are harbingers of G the sea being pulled at any time fierce market, in particular, has been designated the company as the only participation "MDR-TB" Global cooperation project China's pharmaceutical industry is the world's second Eli Lilly and Company to take advantage of patented technology to produce high-quality capreomycin company, also means that the company has entered, including the World Health Organization, Harvard Medical School and Purdue University, as well as high-prevalence countries the leading pharmaceutical companies and the government and other relevant parties to international cooperation in the circle. We are not difficult to imagine such a monopoly, the unique concept of TB antibiotics, pharmaceutical stocks in today's atmosphere of continuous limit-market company's share price will bring about what Think maybe they would feel excited about this kind of material does it mean that G Hai-ching (600,267) of the outbreak coming?! At the same time the unit is also equipped with a powerful double compensatory growth momentum, I believe that once the outbreak of the intensity of amazing. We might as well wait and see.
